Bonemas is a tablet made by Incepta Pharmaceuticals Ltd. It contains the generic medicine alendronic acid and comes in a 10 mg strength. Doctors prescribe it as part of treatment for certain bone conditions.
There are 4 brands of Alendronic Acid listed in Bangladesh. By unit price, Bonemas is among the cheapest of them.
What is Bonemas 10 mg Tablet?
Bonemas is a tablet manufactured by Incepta Pharmaceuticals Ltd. Its active ingredient is alendronic acid, which belongs to a group of medicines called bisphosphonates. These medicines work on the bone by slowing down the cells that break bone down, which helps bone mass. Bonemas is available in a 10 mg strength and is supplied in a pack of 10 tablets. It is used in the treatment of osteoporosis in postmenopausal women, where it helps increase bone mass and reduce the chance of fractures, including those of the hip and spine.
Uses of Bonemas
Bonemas is used for the treatment of osteoporosis in postmenopausal women. In this condition, the medicine helps to increase bone mass and lowers the incidence of fractures, including fractures of the hip and spine. It is a bisphosphonate preparation. Your doctor will decide whether Bonemas is suitable for your situation and will explain what it is being used for in your case.
How to use Bonemas
Take Bonemas exactly as your doctor tells you. The doctor decides the dose and how long the course should last. Swallow the tablet with water as instructed, and follow any directions your doctor or pharmacist gives you about timing and posture. Do not change the dose or stop the medicine on your own. If you are unsure how to take it, ask your doctor or pharmacist for guidance.
Side effects of Bonemas
Like all medicines, Bonemas can cause side effects. The most common include constipation, diarrhoea, flatulence, difficulty swallowing, oesophageal ulcer, muscle and joint pain and headache. Less common effects include nausea, vomiting, rash, redness of the skin, peptic ulceration and allergic reactions such as hives and swelling. A temporary fall in blood calcium and phosphate has also been reported. Tell your doctor promptly if you notice any side effect, especially if it is new, severe or does not go away.
Safety and precautions
Bonemas should not be used in pregnancy or while breastfeeding. Tell your doctor before starting if you are pregnant, planning a pregnancy or nursing. It is not suitable for people with certain oesophageal problems, low blood calcium, or those unable to sit or stand upright as instructed, and it should not be given to anyone allergic to any ingredient. Upper gastrointestinal problems, severe bone, joint or muscle pain, jaw problems and unusual thigh fractures have been reported with medicines like this. Your doctor will assess your risks and correct low calcium before use. Always ask your doctor first if you have stomach or swallowing problems, kidney problems or take other medicines.
Frequently asked questions
What does the generic name alendronic acid mean?
Alendronic acid is the name of the active substance in Bonemas. It is a bisphosphonate medicine that works on bone by reducing the activity of the cells that break bone down. Bonemas is simply the brand name given by the manufacturer, Incepta Pharmaceuticals Ltd.
What is Bonemas used for and what kind of medicine is it?
Bonemas is a bisphosphonate preparation used for the treatment of osteoporosis in postmenopausal women, where it helps increase bone mass and reduce the incidence of fractures, including those of the hip and spine. Your doctor will decide whether it is appropriate for you.
What do the dosage form and strength mean?
Bonemas comes as a tablet, which is a solid form you swallow. The strength is 10 mg, meaning each tablet contains 10 mg of alendronic acid. The pack holds 10 tablets. The doctor decides the dose and course; do not choose them yourself.
What is the price of Bonemas?
The listed price is ৳ 30.00. Ask your pharmacist about the current price and any available pack sizes, as prices can change.
Treatment of Osteoporosis in Postmenopausal Women: Alendronic acid is indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, Alendronic acid increases bone mass and reduces the incidence of fractures, including those of the hip and spine.
... Read more
Alendronic acid is indicated for the-
Treatment of Osteoporosis in Postmenopausal Women: Alendronic acid is indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, Alendronic acid increases bone mass and reduces the incidence of fractures, including those of the hip and spine.
Prevention of Osteoporosis in Postmenopausal Women: Alendronic acid is indicated for the prevention of postmenopausal osteoporosis.
Treatment to Increase Bone Mass in Men with Osteoporosis: Alendronic acid is indicated for treatment to increase bone mass in men with osteoporosis.
Treatment of Glucocorticoid-Induced Osteoporosis: Alendronic acid is indicated for the treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone and who have low bone mineral density.
Treatment of Paget's Disease of Bone: Alendronic acid is indicated for the treatment of Paget’s disease of bone in men and women. Treatment is indicated in patients with Paget's disease of bone who have alkaline phosphatase at least two times the upper limit of normal, or those who are symptomatic, or those at risk for future complications from their disease.
Pharmacology
Alendronate is a bisphosphonate that binds to bone hydroxyapatite and specifically inhibits the activity of osteoclasts, the bone-resorbing cells. Alendronate reduces bone resorption with no direct effect on bone formation, although the latter process is ultimately reduced because bone resorption and formation are coupled during bone turnover.
Animal studies have indicated the following mode of action. At the cellular level, alendronate shows preferential localization to sites of bone resorption, specifically under osteoclasts. The osteoclasts adhere normally to the bone surface but lack the ruffled border that is indicative of active resorption. Alendronate does not interfere with osteoclast recruitment or attachment, but it does inhibit osteoclast activity. Studies in mice on the localization of radioactive [3H] alendronate in bone showed about 10-fold higher uptake on osteoclast surfaces than on osteoblast surfaces. Bones examined 6 and 49 days after [3H] alendronate administration in rats and mice, respectively, showed that normal bone was formed on top of the alendronate, which was incorporated inside the matrix. While incorporated in bone matrix, alendronate is not pharmacologically active. Thus, alendronate must be continuously administered to suppress osteoclasts on newly formed resorption surfaces. Histomorphometry in baboons and rats showed that alendronate treatment reduces bone turnover (i.e., the number of sites at which bone is remodeled). In addition, bone formation exceeds bone resorption at these remodeling sites, leading to progressive gains in bone mass.
Dosage & Administration
Treatment of Osteoporosis in Postmenopausal Women: The recommended dosage is one 70 mg tablet once weekly or one bottle of 70 mg oral solution once weekly or one 10 mg tablet once daily.
Prevention of Osteoporosis in Postmenopausal Women: The recommended dosage is one 35 mg tablet once weekly or one 5 mg tablet once daily.
Treatment to Increase Bone Mass in Men with Osteoporosis: The recommended dosage is one 70 mg tablet once weekly or one bottle of 70 mg oral solution once weekly or one 10 mg tablet once daily.
Treatment of Glucocorticoid-Induced Osteoporosis: The recommended dosage is one 5 mg tablet once daily, except for postmenopausal women not receiving estrogen, for whom the recommended dosage is one 10 mg tablet once daily.
Treatment of Paget's Disease of Bone: The recommended treatment regimen is 40 mg once a day for six months.
Interaction
The incidence of upper gastrointestinal side effects are increased with the concomitant use of non-steroidal anti-inflammatory agents and aspirin. Absorption of Alendronate is reduced in the presence of antacids and calcium supplements.
Contraindications
Alendronic acid is contraindicated in patients with the following conditions:
Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia.
Inability to stand or sit upright for at least 30 minutes.
Do not administer Alendronic acid oral solution to patients at increased risk of aspiration.
Hypocalcemia.
Hypersensitivity to any component of this product. Hypersensitivity reactions including urticaria and angioedema have been reported.
Side Effects
The commonest symptomatic side effects are constipation, diarrhoea, oesophageal ulcer, flatulence, dysphagia, musculoskeletal pain, headache, rarely rash, erythema, transient decrease in serum calcium and phosphate, nausea, vomiting, peptic ulceration, hypersensitivity reactions including urticaria and angio-oedema.
Pregnancy & Lactation
Alendronic acid should not be given to pregnant women or nursing mother.
Precautions & Warnings
Upper Gastrointestinal Adverse Reactions can occur. Instruct patients to follow dosing instructions. Discontinue if new or worsening symptoms occur.
Hypocalcemia can worsen and must be corrected prior to use.
Severe Bone, Joint, Muscle Pain may occur. Discontinue use if severe symptoms develop.
Osteonecrosis of the Jaw has been reported.
Atypical Femur Fractures have been reported. Patients with new thigh or groin pain should be evaluated to rule out an incomplete femoral fracture.
Storage Conditions
Store in a well-closed container at room temperature, 15-30°C
Alternative brands of Alendronic Acid
Other brands with the same generic name, cheapest first.